{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:50:57Z","timestamp":1776372657756,"version":"3.51.2"},"publisher-location":"New York, NY","reference-count":106,"publisher":"Springer New York","isbn-type":[{"value":"9781493995530","type":"print"},{"value":"9781493995547","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9554-7_29","type":"book-chapter","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:39:21Z","timestamp":1562251161000},"page":"493-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Contribution of Inflammation to Autism Spectrum Disorders: Recent Clinical Evidence"],"prefix":"10.1007","author":[{"given":"J.","family":"Prata","sequence":"first","affiliation":[]},{"given":"A. S.","family":"Machado","sequence":"additional","affiliation":[]},{"given":"O.","family":"von Doellinger","sequence":"additional","affiliation":[]},{"given":"M. I.","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"M. A.","family":"Barbosa","sequence":"additional","affiliation":[]},{"given":"R.","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"S. G.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6503a1","volume":"65","author":"D Christensen","year":"2016","unstructured":"Christensen D, Baio J, Braun K, Bilder D, Charles J, Constantino J, Daniels J, Durkin M, Fitzgerald R, Kurzius-Spencer M, Lee L-C, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate M, Zahorodny W, Yeargin-Allsopp M (2016) Prevalence and characteristics of autism spectrum disorder among children aged 8 years \u2014 autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ 65:1\u201323","journal-title":"MMWR Surveill Summ"},{"key":"29_CR2","first-page":"1557","volume-title":"Drug metabolism and disposition: the biological fate of chemicals","author":"CS Rosenfeld","year":"2015","unstructured":"Rosenfeld CS (2015) Microbiome disturbances and autism spectrum disorders. In: Drug metabolism and disposition: the biological fate of chemicals, vol 43, pp 1557\u20131571"},{"key":"29_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ridd.2010.11.003","volume":"32","author":"L Wing","year":"2011","unstructured":"Wing L, Gould J, Gillberg C (2011) Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res Dev Disabil 32:768\u2013773","journal-title":"Res Dev Disabil"},{"key":"29_CR4","volume-title":"Sensory perceptual issues in autism and Asperger syndrome: different sensory experiences - different perceptual worlds","author":"O Bogdashina","year":"2003","unstructured":"Bogdashina O (2003) Sensory perceptual issues in autism and Asperger syndrome: different sensory experiences - different perceptual worlds. Jessica Kingsley Publishers, London"},{"key":"29_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fped.2014.00058","volume":"2","author":"G Vivanti","year":"2014","unstructured":"Vivanti G, Prior M, Williams K, Dissanayake C (2014) Predictors of outcomes in autism early intervention: why don\u2019t we know more? Front Pediatr 2:58","journal-title":"Front Pediatr"},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","volume":"135","author":"K Jobski","year":"2017","unstructured":"Jobski K, H\u00f6fer J, Hoffmann F, Bachmann C (2017) Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatr Scand 135:8\u201328","journal-title":"Acta Psychiatr Scand"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ng.3039","volume":"46","author":"T Gaugler","year":"2014","unstructured":"Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, Mahajan M, Manaa D, Pawitan Y, Reichert J, Ripke S, Sandin S (2014) Most genetic risk for autism resides with common variation. Nat Genet 46:881\u2013885","journal-title":"Nat Genet"},{"key":"29_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.nurt.2010.05.011","volume":"7","author":"S Bent","year":"2010","unstructured":"Bent S, Hendren RL (2010) Improving the prediction of response to therapy in autism. Neurotherapeutics 7:232\u2013240","journal-title":"Neurotherapeutics"},{"key":"29_CR9","volume":"2015","author":"N Xu","year":"2015","unstructured":"Xu N, Li X, Zhong Y (2015) Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators Inflamm 2015:531518","journal-title":"Mediators Inflamm"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.biopsych.2016.08.024","volume":"81","author":"HE Vuong","year":"2017","unstructured":"Vuong HE, Hsiao EY (2017) Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81:411\u2013423","journal-title":"Biol Psychiatry"},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.patbio.2014.10.003","volume":"63","author":"G Fond","year":"2015","unstructured":"Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N, Dickerson F, Macgregor A, Boyer L, Dargel A, Oliveira J, Tamouza R, Leboyer M (2015) The \u201cpsychomicrobiotic\u201d: targeting microbiota in major psychiatric disorders: a systematic review. Pathol Biol 63:35\u201342","journal-title":"Pathol Biol"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S1740925X12000142","volume":"7","author":"JI Rodriguez","year":"2011","unstructured":"Rodriguez JI, Kern JK (2011) Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol 7:205\u2013213","journal-title":"Neuron Glia Biol"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000398791","volume":"37","author":"T Takano","year":"2015","unstructured":"Takano T (2015) Role of microglia in autism: recent advances. Dev Neurosci 37:195\u2013202","journal-title":"Dev Neurosci"},{"key":"29_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193\u2013201","journal-title":"Nat Rev Neurol"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fncel.2013.00045","volume":"7","author":"F Ginhoux","year":"2013","unstructured":"Ginhoux F, Lim S, Hoeffel G, Low D, Huber T (2013) Origin and differentiation of microglia. Front Cell Neurosci 7:45","journal-title":"Front Cell Neurosci"},{"key":"29_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12974-017-0938-y","volume":"14","author":"J Prata","year":"2017","unstructured":"Prata J, Santos SG, Almeida MI, Coelho R, Barbosa MA (2017) Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations. J Neuroinflammation 14:179","journal-title":"J Neuroinflammation"},{"key":"29_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","volume":"35","author":"VH Perry","year":"2013","unstructured":"Perry VH, Teeling J (2013) Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol 35:601\u2013612","journal-title":"Semin Immunopathol"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1007\/s00018-014-1670-8","volume":"71","author":"A Fernandes","year":"2014","unstructured":"Fernandes A, Miller-Fleming L, Pais TF (2014) Microglia and inflammation: conspiracy, controversy or control? Cell Mol Life Sci 71:3969\u20133985","journal-title":"Cell Mol Life Sci"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbi.2008.08.001","volume":"23","author":"AM Enstrom","year":"2009","unstructured":"Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Sharp FR, Ashwood P (2009) Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 23:124\u2013133","journal-title":"Brain Behav Immun"},{"key":"29_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00004583-198705000-00008","volume":"26","author":"RP Warren","year":"1987","unstructured":"Warren RP, Foster A, Margaretten NC (1987) Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 26:333\u2013335","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","volume":"207","author":"X Li","year":"2009","unstructured":"Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M (2009) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207:111\u2013116","journal-title":"J Neuroimmunol"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamapsychiatry.2013.272","volume":"70","author":"K Suzuki","year":"2013","unstructured":"Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, Yoshihara Y, Omata K, Matsumoto K, Tsuchiya KJ, Iwata Y, Tsujii M, Sugiyama T, Mori N (2013) Microglial activation in young adults with autism spectrum disorder. JAMA Psychiat 70:49\u201358","journal-title":"JAMA Psychiat"},{"key":"29_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ph10040095","volume":"10","author":"HO Kalkman","year":"2017","unstructured":"Kalkman HO, Feuerbach D (2017) Microglia M2A polarization as potential link between food allergy and autism spectrum disorders. Pharmaceuticals (Basel) 10:pii: E95","journal-title":"Pharmaceuticals (Basel)"},{"key":"29_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.conb.2007.01.009","volume":"17","author":"DH Geschwind","year":"2007","unstructured":"Geschwind DH, Levitt P (2007) Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 17:103\u2013111","journal-title":"Curr Opin Neurobiol"},{"key":"29_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13229-016-0068-x","volume":"7","author":"AM Young","year":"2016","unstructured":"Young AM, Chakrabarti B, Roberts D, Lai MC, Suckling J, Baron-Cohen S (2016) From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition. Mol Autism 7:9","journal-title":"Mol Autism"},{"key":"29_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.173","volume":"7","author":"K Ishizuka","year":"2017","unstructured":"Ishizuka K, Fujita Y, Kawabata T, Kimura H, Iwayama Y, Inada T, Okahisa Y, Egawa J, Usami M, Kushima I, Uno Y, Okada T, Ikeda M, Aleksic B, Mori D, Someya T, Yoshikawa T, Iwata N, Nakamura H, Yamashita T, Ozaki N (2017) Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders. Transl Psychiatry 7:e1184","journal-title":"Transl Psychiatry"},{"key":"29_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneurol.2014.187","volume":"10","author":"I Knuesel","year":"2014","unstructured":"Knuesel I, Chicha L, Britschgi M, Schobel SA, Bodmer M, Hellings JA, Toovey S, Prinssen EP (2014) Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 10:643\u2013660","journal-title":"Nat Rev Neurol"},{"key":"29_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67\u201381","journal-title":"Ann Neurol"},{"key":"29_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.biopsych.2015.08.036","volume":"81","author":"M Careaga","year":"2017","unstructured":"Careaga M, Rogers S, Hansen RL, Amaral DG, Van de Water J, Ashwood P (2017) Immune endophenotypes in children with autism spectrum disorder. Biol Psychiatry 81:434\u2013441","journal-title":"Biol Psychiatry"},{"key":"29_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-016-0115-7","volume":"8","author":"CA Pardo","year":"2017","unstructured":"Pardo CA, Farmer CA, Thurm A, Shebl FM, Ilieva J, Kalra S, Swedo S (2017) Serum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal study. Mol Autism 8:1","journal-title":"Mol Autism"},{"key":"29_CR31","volume-title":"Roitt\u2019s essential immunology","author":"PJ Delves","year":"2011","unstructured":"Delves PJ, MArtin SJ, Burton DR, Roitt IM (2011) Roitt\u2019s essential immunology, 12th edn. Wiley-Blackwell, London","edition":"12"},{"key":"29_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000330247","volume":"19","author":"MA Erickson","year":"2012","unstructured":"Erickson MA, Dohi K, Banks WA (2012) Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation 19:121\u2013130","journal-title":"Neuroimmunomodulation"},{"key":"29_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2040-2392-2-13","volume":"2","author":"PE Goines","year":"2011","unstructured":"Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, Kharrazi M, Ashwood P, Van de Water J (2011) Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol Autism 2:13","journal-title":"Mol Autism"},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/mp.2010.102","volume":"16","author":"E Schwarz","year":"2011","unstructured":"Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, Ruta L, Kent L, Spain M, Baron-Cohen S, Bahn S (2011) Sex-specific serum biomarker patterns in adults with Asperger\u2019s syndrome. Mol Psychiatry 16:1213\u20131220","journal-title":"Mol Psychiatry"},{"key":"29_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cyto.2012.11.015","volume":"61","author":"MW Abdallah","year":"2013","unstructured":"Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard-Pedersen B, Hougaard DM, Mortensen EL (2013) Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study. Cytokine 61:370\u2013376","journal-title":"Cytokine"},{"key":"29_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.biopsych.2015.08.007","volume":"81","author":"P Krakowiak","year":"2017","unstructured":"Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, Van de Water J (2017) Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatry 81:442\u2013451","journal-title":"Biol Psychiatry"},{"key":"29_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","volume":"33","author":"A Masi","year":"2017","unstructured":"Masi A, Glozier N, Dale R, Guastella AJ (2017) The immune system, cytokines, and biomarkers in autism spectrum disorder. Neurosci Bull 33:194\u2013204","journal-title":"Neurosci Bull"},{"key":"29_CR38","doi-asserted-by":"publisher","first-page":"82390","DOI":"10.18632\/oncotarget.19326","volume":"8","author":"J Xie","year":"2017","unstructured":"Xie J, Huang L, Li X, Li H, Zhou Y, Zhu H, Pan T, Kendrick KM, Xu W (2017) Immunological cytokine profiling identifies TNF-alpha as a key molecule dysregulated in autistic children. Oncotarget 8:82390\u201382398","journal-title":"Oncotarget"},{"key":"29_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020470","volume":"6","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N (2011) Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 6:e20470","journal-title":"PLoS One"},{"key":"29_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/mp.2014.59","volume":"20","author":"A Masi","year":"2015","unstructured":"Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ (2015) Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20:440\u2013446","journal-title":"Mol Psychiatry"},{"key":"29_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163\u2013189","journal-title":"J Leukoc Biol"},{"key":"29_CR42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1176\/ajp.150.8.1189","volume":"150","author":"M Maes","year":"1993","unstructured":"Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E (1993) Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 150:1189\u20131193","journal-title":"Am J Psychiatry"},{"key":"29_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncprheum0338","volume":"2","author":"N Nishimoto","year":"2006","unstructured":"Nishimoto N, Kishimoto T (2006) Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2:619\u2013626","journal-title":"Nat Clin Pract Rheumatol"},{"key":"29_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbadis.2012.01.011","volume":"1822","author":"H Wei","year":"2012","unstructured":"Wei H, Chadman KK, McCloskey DP, Sheikh AM, Malik M, Brown WT, Li X (2012) Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. Biochim Biophys Acta 1822:831\u2013842","journal-title":"Biochim Biophys Acta"},{"key":"29_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2012.06634.x","volume":"1261","author":"N Rohleder","year":"2012","unstructured":"Rohleder N, Aringer M, Boentert M (2012) Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 1261:88\u201396","journal-title":"Ann N Y Acad Sci"},{"key":"29_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijdevneu.2005.04.001","volume":"23","author":"FC Gomes","year":"2005","unstructured":"Gomes FC, Sousa Vde O, Romao L (2005) Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 23:413\u2013424","journal-title":"Int J Dev Neurosci"},{"key":"29_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12640-013-9393-4","volume":"24","author":"S Ricci","year":"2013","unstructured":"Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, Archer T (2013) Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res 24:491\u2013501","journal-title":"Neurotox Res"},{"key":"29_CR48","first-page":"11","volume":"8","author":"YM Han","year":"2017","unstructured":"Han YM, Cheung WK, Wong CK, Sze SL, Cheng TW, Yeung MK, Chan AS (2017) Distinct cytokine and chemokine profiles in autism spectrum disorders. Front Immunol 8:11","journal-title":"Front Immunol"},{"key":"29_CR49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/aur.1254","volume":"5","author":"MW Abdallah","year":"2012","unstructured":"Abdallah MW, Pearce BD, Larsen N, Greaves-Lord K, Norgaard-Pedersen B, Hougaard DM, Mortensen EL, Grove J (2012) Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study. Autism Res 5:428\u2013433","journal-title":"Autism Res"},{"key":"29_CR50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1189\/jlb.0607338","volume":"82","author":"P Van Lint","year":"2007","unstructured":"Van Lint P, Libert C (2007) Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82:1375\u20131381","journal-title":"J Leukoc Biol"},{"key":"29_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/161358","volume":"2011","author":"JW Critchfield","year":"2011","unstructured":"Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P (2011) The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011:161358","journal-title":"Gastroenterol Res Pract"},{"key":"29_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbi.2010.09.002","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J (2011) Altered T cell responses in children with autism. Brain Behav Immun 25:840\u2013849","journal-title":"Brain Behav Immun"},{"key":"29_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2015.07.003","volume":"286","author":"ME Akintunde","year":"2015","unstructured":"Akintunde ME, Rose M, Krakowiak P, Heuer L, Ashwood P, Hansen R, Hertz-Picciotto I, Van de Water J (2015) Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma. J Neuroimmunol 286:33\u201341","journal-title":"J Neuroimmunol"},{"key":"29_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuroscience.2017.06.012","volume":"370","author":"FR Guerini","year":"2018","unstructured":"Guerini FR, Bolognesi E, Chiappedi M, Ghezzo A, Manca S, Zanette M, Sotgiu S, Mensi MM, Zanzottera M, Agliardi C, Costa AS, Balottin U, Clerici M (2018) HLA-G \u221714bp insertion and the KIR2DS1-HLAC2 complex impact on behavioral impairment in children with autism spectrum disorders. Neuroscience 370:163\u2013169","journal-title":"Neuroscience"},{"key":"29_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbi.2017.09.007","volume":"67","author":"FR Guerini","year":"2018","unstructured":"Guerini FR, Bolognesi E, Chiappedi M, Ripamonti E, Ghezzo A, Zanette M, Sotgiu S, Mensi MM, Carta A, Canevini MP, Zanzottera M, Agliardi C, Costa AS, Balottin U, Clerici M (2018) HLA-G coding region polymorphism is skewed in autistic spectrum disorders. Brain Behav Immun 67:308\u2013313","journal-title":"Brain Behav Immun"},{"key":"29_CR56","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/npp.2016.158","volume":"42","author":"A Meltzer","year":"2017","unstructured":"Meltzer A, Van de Water J (2017) The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 42:284\u2013298","journal-title":"Neuropsychopharmacology"},{"key":"29_CR57","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fnhum.2013.00738","volume":"7","author":"I Voineagu","year":"2013","unstructured":"Voineagu I, Eapen V (2013) Converging pathways in autism spectrum disorders: interplay between synaptic dysfunction and immune responses. Front Hum Neurosci 7:738","journal-title":"Front Hum Neurosci"},{"key":"29_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10110","volume":"474","author":"I Voineagu","year":"2011","unstructured":"Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380\u2013384","journal-title":"Nature"},{"key":"29_CR59","first-page":"27","volume":"2","author":"AM Young","year":"2011","unstructured":"Young AM, Campbell E, Lynch S, Suckling J, Powis SJ (2011) Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation. Front Psych 2:27","journal-title":"Front Psych"},{"key":"29_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/aur.1657","volume":"10","author":"P Krakowiak","year":"2017","unstructured":"Krakowiak P, Walker CK, Tancredi D, Hertz-Picciotto I, Van de Water J (2017) Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions. Autism Res 10:89\u201398","journal-title":"Autism Res"},{"key":"29_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mcn.2012.10.003","volume":"53","author":"AM Depino","year":"2013","unstructured":"Depino AM (2013) Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci 53:69\u201376","journal-title":"Mol Cell Neurosci"},{"key":"29_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40\u201345","journal-title":"Brain Behav Immun"},{"key":"29_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.neuroscience.2014.10.011","volume":"284","author":"CJ Yang","year":"2015","unstructured":"Yang CJ, Liu CL, Sang B, Zhu XM, Du YJ (2015) The combined role of serotonin and interleukin-6 as biomarker for autism. Neuroscience 284:290\u2013296","journal-title":"Neuroscience"},{"key":"29_CR64","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.rasd.2014.10.012","volume":"9","author":"C-J Yang","year":"2015","unstructured":"Yang C-J, Tan H-P, Yang F-Y, Liu C-L, Sang B, Zhu X-M, Du Y-J (2015) The roles of cortisol and pro-inflammatory cytokines in assisting the diagnosis of autism spectrum disorder. Res Autism Spectr Disord 9:174\u2013181","journal-title":"Res Autism Spectr Disord"},{"key":"29_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jneuroim.2008.07.006","volume":"204","author":"P Ashwood","year":"2008","unstructured":"Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, Van de Water J (2008) Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 204:149\u2013153","journal-title":"J Neuroimmunol"},{"key":"29_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejenta.2014.12.002","volume":"16","author":"T Mohamed El Gohary","year":"2015","unstructured":"Mohamed El Gohary T, Abd El Aziz N, Darweesh M, Shukery Sadaa E (2015) Plasma level of transforming growth factor \u03b2 1 in children with autism spectrum disorder. Egy J Ear Nose Throat Allied Sci 16:69","journal-title":"Egy J Ear Nose Throat Allied Sci"},{"key":"29_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/aur.42","volume":"1","author":"L Heuer","year":"2008","unstructured":"Heuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water J (2008) Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res 1:275\u2013283","journal-title":"Autism Res"},{"key":"29_CR68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1742-2094-8-39","volume":"8","author":"GA Mostafa","year":"2011","unstructured":"Mostafa GA, Al-Ayadhi LY (2011) Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation 8:39","journal-title":"J Neuroinflammation"},{"key":"29_CR69","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejpn.2011.12.010","volume":"16","author":"GA Mostafa","year":"2012","unstructured":"Mostafa GA, Al-Ayadhi LY (2012) The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur J Paediatr Neurol 16:464\u2013468","journal-title":"Eur J Paediatr Neurol"},{"key":"29_CR70","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/935608","volume":"2013","author":"M Careaga","year":"2013","unstructured":"Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P (2013) Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm 2013:935608","journal-title":"Mediators Inflamm"},{"issue":"Suppl 1","key":"29_CR71","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1542\/peds.2009-1878C","volume":"125","author":"T Buie","year":"2010","unstructured":"Buie T, Campbell DB, Fuchs GJ III, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H (2010) Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125(Suppl 1):S1\u2013S18","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"29_CR72","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1542\/peds.2012-0900N","volume":"130","author":"DL Coury","year":"2012","unstructured":"Coury DL, Ashwood P, Fasano A, Fuchs G, Geraghty M, Kaul A, Mawe G, Patterson P, Jones NE (2012) Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics 130(Suppl 2):S160\u2013S168","journal-title":"Pediatrics"},{"key":"29_CR73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10802-012-9668-x","volume":"41","author":"MO Mazurek","year":"2013","unstructured":"Mazurek MO, Vasa RA, Kalb LG, Kanne SM, Rosenberg D, Keefer A, Murray DS, Freedman B, Lowery LA (2013) Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. J Abnorm Child Psychol 41:165\u2013176","journal-title":"J Abnorm Child Psychol"},{"key":"29_CR74","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/00004703-200604002-00011","volume":"27","author":"M Valicenti-McDermott","year":"2006","unstructured":"Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S (2006) Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 27:S128\u2013S136","journal-title":"J Dev Behav Pediatr"},{"key":"29_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-230X-11-22","volume":"11","author":"JB Adams","year":"2011","unstructured":"Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol 11:22","journal-title":"BMC Gastroenterol"},{"key":"29_CR76","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10803-006-0141-y","volume":"36","author":"CK Schneider","year":"2006","unstructured":"Schneider CK, Melmed RD, Barstow LE, Enriquez FJ, Ranger-Moore J, Ostrem JA (2006) Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study. J Autism Dev Disord 36:1053\u20131064","journal-title":"J Autism Dev Disord"},{"key":"29_CR77","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/DBP.0b013e31821bd06a","volume":"32","author":"LW Wang","year":"2011","unstructured":"Wang LW, Tancredi DJ, Thomas DW (2011) The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J Dev Behav Pediatr 32:351\u2013360","journal-title":"J Dev Behav Pediatr"},{"key":"29_CR78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer F, Backhed F (2013) The gut microbiota--masters of host development and physiology. Nat Rev Microbiol 11:227\u2013238","journal-title":"Nat Rev Microbiol"},{"key":"29_CR79","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.3748\/wjg.v22.i46.10093","volume":"22","author":"F Navarro","year":"2016","unstructured":"Navarro F, Liu Y, Rhoads JM (2016) Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol 22:10093\u201310102","journal-title":"World J Gastroenterol"},{"key":"29_CR80","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.anaerobe.2010.06.008","volume":"16","author":"SM Finegold","year":"2010","unstructured":"Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA 3rd. (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16:444\u2013453","journal-title":"Anaerobe"},{"key":"29_CR81","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.anaerobe.2011.12.018","volume":"18","author":"SM Finegold","year":"2012","unstructured":"Finegold SM, Downes J, Summanen PH (2012) Microbiology of regressive autism. Anaerobe 18:260\u2013262","journal-title":"Anaerobe"},{"key":"29_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068322","volume":"8","author":"DW Kang","year":"2013","unstructured":"Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8:e68322","journal-title":"PLoS One"},{"key":"29_CR83","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1099\/jmm.0.46101-0","volume":"54","author":"HM Parracho","year":"2005","unstructured":"Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54:987\u2013991","journal-title":"J Med Microbiol"},{"key":"29_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076993","volume":"8","author":"M De Angelis","year":"2013","unstructured":"De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R (2013) Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One 8:e76993","journal-title":"PLoS One"},{"key":"29_CR85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.anaerobe.2017.12.007","volume":"49","author":"DW Kang","year":"2018","unstructured":"Kang DW, Ilhan ZE, Isern NG, Hoyt DW, Howsmon DP, Shaffer M, Lozupone CA, Hahn J, Adams JB, Krajmalnik-Brown R (2018) Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. Anaerobe 49:121\u2013131","journal-title":"Anaerobe"},{"key":"29_CR86","doi-asserted-by":"publisher","first-page":"S517","DOI":"10.33549\/physiolres.933801","volume":"66","author":"K Babinska","year":"2017","unstructured":"Babinska K, Tomova A, Celusakova H, Babkova J, Repiska G, Kubranska A, Filcikova D, Siklenkova L, Ostatnikova D (2017) Fecal calprotectin levels correlate with main domains of the autism diagnostic interview-revised (ADI-R) in a sample of individuals with autism spectrum disorders from Slovakia. Physiol Res 66:S517\u2013S522","journal-title":"Physiol Res"},{"key":"29_CR87","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/nutrit\/nuw048","volume":"74","author":"K Berding","year":"2016","unstructured":"Berding K, Donovan SM (2016) Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs. Nutr Rev 74:723\u2013736","journal-title":"Nutr Rev"},{"key":"29_CR88","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.yhbeh.2012.02.018","volume":"62","author":"JM Schwarz","year":"2012","unstructured":"Schwarz JM, Bilbo SD (2012) Sex, glia, and development: interactions in health and disease. Horm Behav 62:243\u2013253","journal-title":"Horm Behav"},{"key":"29_CR89","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","volume":"33","author":"T Schneider","year":"2008","unstructured":"Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, Przewlocki R (2008) Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33:728\u2013740","journal-title":"Psychoneuroendocrinology"},{"key":"29_CR90","doi-asserted-by":"publisher","first-page":"459","DOI":"10.31887\/DCNS.2016.18.4\/tbale","volume":"18","author":"TL Bale","year":"2016","unstructured":"Bale TL (2016) The placenta and neurodevelopment: sex differences in prenatal vulnerability. Dialogues Clin Neurosci 18:459\u2013464","journal-title":"Dialogues Clin Neurosci"},{"key":"29_CR91","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1210\/en.2014-1040","volume":"155","author":"SL Bronson","year":"2014","unstructured":"Bronson SL, Bale TL (2014) Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology 155:2635\u20132646","journal-title":"Endocrinology"},{"key":"29_CR92","doi-asserted-by":"publisher","first-page":"9055","DOI":"10.1523\/JNEUROSCI.1424-08.2008","volume":"28","author":"BR Mueller","year":"2008","unstructured":"Mueller BR, Bale TL (2008) Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 28:9055\u20139065","journal-title":"J Neurosci"},{"key":"29_CR93","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2040-2392-5-4","volume":"5","author":"H Steeb","year":"2014","unstructured":"Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, Ingudomnukul E, Auyeung B, Ruta L, Baron-Cohen S, Bahn S (2014) Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism 5:4","journal-title":"Mol Autism"},{"key":"29_CR94","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13229-017-0176-2","volume":"8","author":"A Masi","year":"2017","unstructured":"Masi A, Breen EJ, Alvares GA, Glozier N, Hickie IB, Hunt A, Hui J, Beilby J, Ravine D, Wray J, Whitehouse AJO, Guastella AJ (2017) Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. Mol Autism 8:63","journal-title":"Mol Autism"},{"key":"29_CR95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160:62\u201373","journal-title":"Cell"},{"key":"29_CR96","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","volume":"24","author":"C Sarkar","year":"2010","unstructured":"Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S (2010) The immunoregulatory role of dopamine: an update. Brain Behav Immun 24:525\u2013528","journal-title":"Brain Behav Immun"},{"key":"29_CR97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.3479","volume":"20","author":"R Torres-Rosas","year":"2014","unstructured":"Torres-Rosas R, Yehia G, Pena G, Mishra P, del Rocio Thompson-Bonilla M, Moreno-Eutimio MA, Arriaga-Pizano LA, Isibasi A, Ulloa L (2014) Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med 20:291\u2013295","journal-title":"Nat Med"},{"key":"29_CR98","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1021\/cn300186b","volume":"4","author":"NL Baganz","year":"2013","unstructured":"Baganz NL, Blakely RD (2013) A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Nerosci 4:48\u201363","journal-title":"ACS Chem Nerosci"},{"key":"29_CR99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coph.2011.02.004","volume":"11","author":"GP Ahern","year":"2011","unstructured":"Ahern GP (2011) 5-HT and the immune system. Curr Opin Pharmacol 11:29\u201333","journal-title":"Curr Opin Pharmacol"},{"key":"29_CR100","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/cap.2010.0134","volume":"21","author":"Z Tobiasova","year":"2011","unstructured":"Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, Bothwell AL, Kawikova I (2011) Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol 21:555\u2013564","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"29_CR101","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1089\/cap.2013.0108","volume":"24","author":"JE Choi","year":"2014","unstructured":"Choi JE, Widjaja F, Careaga M, Bent S, Ashwood P, Hendren RL (2014) Change in plasma cytokine levels during risperidone treatment in children with autism. J Child Adolesc Psychopharmacol 24:586\u2013589","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"29_CR102","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pnpbp.2009.09.012","volume":"34","author":"S Akhondzadeh","year":"2010","unstructured":"Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S (2010) Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Prog Neuropsychopharmacol Biol Psychiatry 34:32\u201336","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"29_CR103","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.psychres.2015.07.043","volume":"229","author":"A Ghaleiha","year":"2015","unstructured":"Ghaleiha A, Rasa SM, Nikoo M, Farokhnia M, Mohammadi MR, Akhondzadeh S (2015) A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: effects on aberrant behavior in children with autism. Psychiatry Res 229:181\u2013187","journal-title":"Psychiatry Res"},{"key":"29_CR104","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00213-012-2796-8","volume":"225","author":"M Asadabadi","year":"2013","unstructured":"Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S (2013) Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 225:51\u201359","journal-title":"Psychopharmacology (Berl)"},{"key":"29_CR105","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1038\/tp.2015.142","volume":"5","author":"I Tsilioni","year":"2015","unstructured":"Tsilioni I, Taliou A, Francis K, Theoharides TC (2015) Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry 5:e647","journal-title":"Transl Psychiatry"},{"key":"29_CR106","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/aur.1906","volume":"11","author":"IR Melamed","year":"2018","unstructured":"Melamed IR, Heffron M, Testori A, Lipe K (2018) A pilot study of high-dose intravenous immunoglobulin 5% for autism: impact on autism spectrum and markers of neuroinflammation. Autism Res 11:421\u2013433","journal-title":"Autism Res"}],"container-title":["Methods in Molecular Biology","Psychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9554-7_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T16:20:41Z","timestamp":1649953241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-9554-7_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493995530","9781493995547"],"references-count":106,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9554-7_29","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"5 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}